The appellant, a South African subsidiary of a United States pharmaceutical company, incurred expenditure on so-called 'social responsibility projects' in South Africa pursuant to the Sullivan Code and later the US Comprehensive Anti-Apartheid Act. Compliance with these measures was effectively compulsory for US parent companies, failing which they faced sanctions in the United States. For the 1990–1993 years of assessment, Warner Lambert SA claimed deductions under s 11(a) read with s 23(g) of the Income Tax Act 58 of 1962 for certain social responsibility expenditure aimed at promoting social, economic and political justice. SARS initially allowed but later disallowed the deductions in revised assessments, contending that the expenditure was not incurred in the production of income. On appeal, the Cape Special Income Tax Court assumed the expenditure was incurred in the production of income but held it to be capital in nature and therefore not deductible. Warner Lambert appealed to the Supreme Court of Appeal.